Literature DB >> 24482160

Should we target obesity in advanced heart failure?

Amanda R Vest1, James B Young.   

Abstract

OPINION STATEMENT: Obesity is a risk factor for the development of heart failure (HF), but has been associated with improved survival in patients with established HF. Weight loss should clearly be recommended and supported for obese individuals without cardiac pathology to prevent cardiomyopathy development. Clinical recommendations at the other end of the obesity heart failure spectrum are also relatively clear. Morbidly obese individuals (BMI ≥ 40 kg/m(2)) aged <50 years with severely depressed systolic function and NYHA class III-IV symptoms should be considered for malabsorptive bariatric surgery at an experienced center. The goal is either improved systolic function and symptoms, or sufficient weight loss for heart transplant eligibility. Recommendations for patients falling between these extremes are more challenging. Overweight and mildly obese HF patients (25-35 kg/m(2)) may be somewhat protected from cardiac cachexia and weight loss is not expected to enhance survival, but may offer symptomatic benefits.

Entities:  

Year:  2014        PMID: 24482160     DOI: 10.1007/s11936-013-0284-z

Source DB:  PubMed          Journal:  Curr Treat Options Cardiovasc Med        ISSN: 1092-8464


  96 in total

1.  Cardiac morphology and left ventricular function in normotensive morbidly obese patients with and without congestive heart failure, and effect of weight loss.

Authors:  M A Alpert; B E Terry; M Mulekar; M V Cohen; C V Massey; T M Fan; H Panayiotou; V Mukerji
Journal:  Am J Cardiol       Date:  1997-09-15       Impact factor: 2.778

2.  Adiposopathy is "sick fat" a cardiovascular disease?

Authors:  Harold E Bays
Journal:  J Am Coll Cardiol       Date:  2011-06-21       Impact factor: 24.094

3.  Take heart: bariatric surgery in obese patients with severe heart failure. Two case reports.

Authors:  K Samaras; S M Connolly; R V Lord; P Macdonald; C S Hayward
Journal:  Heart Lung Circ       Date:  2012-06-27       Impact factor: 2.975

4.  Weight loss of 146 kg with diet and reversal of severe congestive heart failure in a young, morbidly obese patient.

Authors:  M Zuber; T Kaeslin; T Studer; P Erne
Journal:  Am J Cardiol       Date:  1999-10-15       Impact factor: 2.778

5.  Overproduction of angiotensinogen from adipose tissue induces adipose inflammation, glucose intolerance, and insulin resistance.

Authors:  Nishan S Kalupahana; Florence Massiera; Annie Quignard-Boulange; Gérard Ailhaud; Brynn H Voy; David H Wasserman; Naima Moustaid-Moussa
Journal:  Obesity (Silver Spring)       Date:  2011-10-06       Impact factor: 5.002

6.  Effects of ghrelin administration on left ventricular function, exercise capacity, and muscle wasting in patients with chronic heart failure.

Authors:  Noritoshi Nagaya; Junji Moriya; Yoshio Yasumura; Masaaki Uematsu; Fumiaki Ono; Wataru Shimizu; Kazuyuki Ueno; Masafumi Kitakaze; Kunio Miyatake; Kenji Kangawa
Journal:  Circulation       Date:  2004-11-29       Impact factor: 29.690

7.  Dramatic reversal of derangements in muscle metabolism and left ventricular function after bariatric surgery.

Authors:  Joshua G Leichman; Erik B Wilson; Terry Scarborough; David Aguilar; Charles C Miller; Sherman Yu; Mohamed F Algahim; Manuel Reyes; Frank G Moody; Heinrich Taegtmeyer
Journal:  Am J Med       Date:  2008-11       Impact factor: 4.965

Review 8.  Lorcaserin and adiposopathy: 5-HT2c agonism as a treatment for 'sick fat' and metabolic disease.

Authors:  Harold E Bays
Journal:  Expert Rev Cardiovasc Ther       Date:  2009-11

9.  Rat heart is a site of leptin production and action.

Authors:  Daniel M Purdham; Min-Xu Zou; Venkatesh Rajapurohitam; Morris Karmazyn
Journal:  Am J Physiol Heart Circ Physiol       Date:  2004-07-29       Impact factor: 4.733

10.  Role of resistin in cardiac contractility and hypertrophy.

Authors:  Maengjo Kim; Jae Kyun Oh; Susumu Sakata; Iifan Liang; Woojin Park; Roger J Hajjar; Djamel Lebeche
Journal:  J Mol Cell Cardiol       Date:  2008-05-20       Impact factor: 5.000

View more
  3 in total

Review 1.  Morbid Obesity as a Therapeutic Target for Heart Failure.

Authors:  Chonyang L Albert
Journal:  Curr Treat Options Cardiovasc Med       Date:  2019-09-05

2.  A Population-Based Study of Early Postoperative Outcomes in Patients with Heart Failure Undergoing Bariatric Surgery.

Authors:  Andrew T Strong; Gautam Sharma; Chao Tu; Ali Aminian; James B Young; John Rodriguez; Matthew Kroh
Journal:  Obes Surg       Date:  2018-08       Impact factor: 4.129

Review 3.  INTERACTING DISCIPLINES: Cardiac natriuretic peptides and obesity: perspectives from an endocrinologist and a cardiologist.

Authors:  Hugo R Ramos; Andreas L Birkenfeld; Adolfo J de Bold
Journal:  Endocr Connect       Date:  2015-09       Impact factor: 3.335

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.